Regulation of monocyte and keratinocyte interleukin 6 production by transforming growth factor beta.
There is strong evidence for a complex network-like interaction between cytokines, growth factors and other mediators being responsible for cell growth and differentiation as well as for the outcome of an inflammatory reaction. Therefore, the regulation of the production of the ubiquitous proinflammatory cytokine interleukin 6 (IL-6) by transforming growth factor beta (TGF beta) was investigated. Human peripheral blood mononuclear cells (PBMC), human normal keratinocytes (HNK), and an epidermoid carcinoma cell line (KB) were treated with TGF beta 1 or TGF beta 2 and subsequently IL-6 secretion was evaluated. Addition of TGF beta 1 as well as TGF beta 2 to PBMC, HNK and KB cells resulted in a significantly increased release of IL-6 activity. The inducing effect of TGF beta was does dependent and maximal when supernatants were harvested 48 h after stimulation. In addition, upon Western blot analysis using a monoclonal IL-6 antibody significantly increased amounts of IL-6 protein were detected in KB cell supernatants following stimulation with TGF beta 1. These results were further confirmed at the transcriptional level using a cDNA probe specific for IL-6 and Northern blot analysis. Accordingly, an increased IL-6 mRNA expression in PBMC or KB cells was detected following TGF beta 1 treatment. These findings indicate that TGF beta in contrast to its antiinflammatory capacities also may stimulate IL-6 production in PBMC and keratinocytes. This further supports the possibly important immunoregulatory role of growth factors such as TGF beta.
Möller
A
A
Department of Dermatology, UKRV, FU Berlin, Germany.
Schwarz
A
A
Neuner
P
P
Schwarz
T
T
Luger
T A
TA
D015152:Blotting, Northern; D015153:Blotting, Western; D002294:Carcinoma, Squamous Cell / Q000473:pathology; D002478:Cells, Cultured; D018076:DNA, Complementary / Q000235:genetics; D005786:Gene Expression Regulation / Q000187:drug effects*; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D015850:Interleukin-6 / Q000096:biosynthesis* / Q000235:genetics; D015603:Keratinocytes / Q000187:drug effects* / Q000378:metabolism; D007963:Leukocytes, Mononuclear / Q000187:drug effects* / Q000378:metabolism; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D014158:Transcription, Genetic; D016212:Transforming Growth Factor beta / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
D018076:DNA, Complementary; D015850:Interleukin-6; D012333:RNA, Messenger; D016212:Transforming Growth Factor beta